Repinotan, a selective 5-HT1A-R-agonist, antagonizes morphine-induced ventilatory depression in anesthetized rats

Anesthesia and Analgesia

Volumn 111, Issue 4, 2010, Pages 901-907

  Guenther, U ^a   Wrigge, H ^a   Theuerkauf, N ^a   Boettcher, M F ^b   Wensing, G ^b   Zinserling, J ^a   Putensen, C ^a   Hoeft, A ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b BAYER PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; NALOXONE; PENTOBARBITAL; REPINOTAN; SEVOFLURANE; SODIUM CHLORIDE; BENZOPYRAN DERIVATIVE; SEROTONIN 1A RECEPTOR; SEROTONIN AGONIST; THIAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; ARTIFICIAL VENTILATION; BREATHING; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG DOSE INCREASE; DRUG EFFECT; DRUG POTENCY; LUNG MINUTE VOLUME; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATION DEPRESSION; TAIL FLICK TEST; ANIMAL; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG POTENTIATION; PHYSIOLOGY; RESPIRATORY FAILURE; SPRAGUE DAWLEY RAT;

ANIMALS; BENZOPYRANS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MORPHINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; RESPIRATORY INSUFFICIENCY; SEROTONIN AGONISTS; THIAZOLES;

EID: 77957701178     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e3181eac011     Document Type: Article

References (45)

1. Couzin J. Medicine: a sigh of relief for painkillers. Science 2003;301:150
2. Garner SJ, Eldridge FL, Wagner PG, Dowell RT. Buspirone, an anxiolytic drug that stimulates respiration. Am Rev Respir Dis 1989;139:946-950
3. Wilken B, Lalley P, Bischoff AM, Christen HJ, Behnke J, Hanefeld F, Richter DW. Treatment of apneustic respiratory disturbance with a serotonin-receptor agonist. J Pediatr 1997;130:89-94
4. El-Khatib MF, Kiwan RA, Jamaleddine GW. Buspirone treatment for apneustic breathing in brain stem infarct. Respir Care 2003;48:956-958
5. Sahibzada N, Ferreira M, Wasserman AM, Taveira-DaSilva AM, Gillis RA. Reversal of morphine-induced apnea in the anesthetized rat by drugs that activate 5-hydroxytryptamine(1A) receptors. J Pharmacol Exp Ther 2000;292:704-713
6. Bardin L, Tarayre JP, Malfetes N, Koek W, Colpaert FC. Profound, non-opioid analgesia produced by the high-efficacy 5-HT(1A) agonist F 13640 in the formalin model of tonic nociceptive pain. Pharmacology 2003;67:182-194
7. Bardin L, Tarayre JP, Koek W, Colpaert FC. In the formalin model of tonic nociceptive pain, 8-OH-DPAT produces 5-HT1A receptor-mediated, behaviorally specific analgesia. Eur J Pharmacol 2001;421:109-114
8. Nadeson R, Goodchild CS. Antinociceptive role of 5-HT1A receptors in rat spinal cord. Br J Anaesth 2002;88:679-684
9. Clarke RW, Ogilvie J, Houghton AK. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino) tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1Aand non-5-HT1A-receptors. Br J Pharmacol 1997;122:631-638
10. Zhang YQ, Gao X, Ji GC, Huang YL, Wu GC, Zhao ZQ. Expression of 5-HT1A receptor mRNA in rat lumbar spinal dorsal horn neurons after peripheral inflammation. Pain 2002;98:287-295
11. Bardin L, Assie MB, Pelissou M, Royer-Urios I, Newman- Tancredi A, Ribet JP, Sautel F, Koek W, Colpaert FC. Dual, hyperalgesic, and analgesic effects of the high-efficacy 5-hydroxytryptamine 1A (5-HT1A) agonist F 13640 [(3-chloro- 4-fluoro-phenyl)-[4-fluoro-4-{[(5-methyl-pyridin-2-ylmethyl)- amino]-methyl}piperidin-1-yl]methanone, fumaric acid salt]: relationship with 5-HT1A receptor occupancy and kinetic parameters. J Pharmacol Exp Ther 2005;312:1034-1042
12. Guenther U, Manzke T, Wrigge H, Dutschmann M, Zinserling J, Putensen C, Hoeft A. The counteraction of opioid-induced ventilatory depression by the serotonin 1A-agonist 8-OHDPAT does not antagonize antinociception in rats in situ and in vivo. Anesth Analg 2009;108:1169-1176
13. De Vry J, Schohe-Loop R, Heine HG, Greuel JM, Mauler F, Schmidt B, Sommermeyer H, Glaser T. Characterization of the aminomethylchroman derivative BAY- 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist. J Pharmacol Exp Ther 1998;284:1082-1094
14. Schwarz T, Beckermann B, Buehner K, Mauler F, Schuhmacher J, Seidel D, Steinke W, Weinz C, Zimmerd D. Pharmacokinetics of repinotan in healthy and brain injured animals. Biopharm Drug Dispos 2005;26:259-268
15. Harkany T, Mulder J, Horvath KM, Keijser J, van der Meeberg EK, Nyakas C, Luiten PG. Oral post-lesion administration of 5-HT(1A) receptor agonist repinotan hydrochloride (BAY- 3702) attenuates NMDA-induced delayed neuronal death in rat magnocellular nucleus basalis. Neuroscience 2001;108:629-642
16. Ohman J, Braakman R, Legout V. Repinotan (BAY- 3702): a 5HT1A agonist in traumatically brain injured patients. J Neurotrauma 2001;18:1313-1321
17. Teal P, Silver FL, Simard D. The BRAINS study: safety, tolerability, and dose-finding of repinotan in acute stroke. Can J Neurol Sci 2005;32:61-67
18. Teal P, Davis S, Hacke W, Kaste M, Lyden PD, Fierus M. A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, tolerability, and pharmacokinetic/ pharmacodynamic effects of a targeted exposure of intravenous repinotan in patients with acute ischemic stroke: modified Randomized Exposure Controlled Trial (mRECT). Stroke 2009;40:3518-3525
19. Motulsky HJ. Analyzing Data with GraphPad Prism. San Diego: GraphPad Software Inc., 1999
20. Oertel BG, Schneider A, Rohrbacher M, Schmidt H, Tegeder I, Geisslinger G, Lotsch J. The partial 5-hydroxytryptamine1A receptor agonist buspirone does not antagonize morphineinduced respiratory depression in humans. Clin Pharmacol Ther 2007;81:59-68
21. Pavlakovic G, Tigges J, Crozier TA. Effect of buspirone on thermal sensory and pain thresholds in human volunteers. BMC Clin Pharmacol 2009;9:12
22. Guenther U, Bischoff A, Kettler D, Richter DW. 5-HT1Aagnoists protect against opioidergic depression of respiration. In: Urban BW, Barann M, eds. Molecular und basic mechanisms of anesthesia D-49525 Lengerich: Papst Science Publishers, 2001:400-403
23. Colpaert FC, Wu WP, Hao JX, Royer I, Sautel F, Wiesenfeld-Hallin Z, Xu XJ. High-efficacy 5-HT1A receptor activation causes a curative-like action on allodynia in rats with spinal cord injury. Eur J Pharmacol 2004;497:29-33
24. Galeotti N, Ghelardini C, Bartolini A. 5-HT1A agonists induce central cholinergic antinociception. Pharmacol Biochem Behav 1997;57:835-841
25. Bardin L, Colpaert FC. Role of spinal 5-HT(1A) receptors in morphine analgesia and tolerance in rats. Eur J Pain 2004;8:253-261
26. Graeff FG. Serotonin, the periaqueductal gray and panic. Neurosci Biobehav Rev 2004;28:239-259
27. Deseure K, Breand S, Colpaert FC. Curative-like analgesia in a neuropathic pain model: parametric analysis of the dose and the duration of treatment with a high-efficacy 5-HT(1A) receptor agonist. Eur J Pharmacol 2007;568:134-141
28. Colpaert FC, Deseure K, Stinus L, Adriaensen H. High-efficacy 5-hydroxytryptamine 1A receptor activation counteracts opioid hyperallodynia and affective conditioning. J Pharmacol Exp Ther 2006;316:892-899
29. Calabrese EJ, Baldwin LA. U-shaped dose-responses in biology, toxicology, and public health. Annu Rev Public Health 2001;22:15-33
30. Calabrese EJ. Hormesis: basic, generalizable, central to toxicology and a method to improve the risk-assessment process. Int J Occup Environ Health 2004;10:466-467
31. Calabrese EJ, Baldwin LA. Hormesis: the dose-response revolution. Annu Rev Pharmacol Toxicol 2003;43:175-197
32. Mauler F, Horvath E. Neuroprotective efficacy of repinotan HCl, a 5-HT1A receptor agonist, in animal models of stroke and traumatic brain injury. J Cereb Blood Flow Metab 2005;25:451-459
33. Clarke RW, Ward RE. The role of 5-HT(1A)-receptors in fentanyl-induced bulbospinal inhibition of a spinal withdrawal reflex in the rabbit. Pain 2000;85:239-245
34. Gjerstad J, Tjolsen A, Hole K. The effect of 5-HT1A receptor stimulation on nociceptive dorsal horn neurones in rats. Eur J Pharmacol 1996;318:315-321
35. Manzke T, Dutschmann M, Schlaf G, Morschel M, Koch UR, Ponimaskin E, Bidon O, Lalley PM, Richter DW. Serotonin targets inhibitory synapses to induce modulation of network functions. Philos Trans R Soc Lond B Biol Sci 2009;364:2589-2602
36. Dutschmann M, Waki H, Manzke T, Simms AE, Pickering AE, Richter DW, Paton JF. The potency of different serotonergic agonists in counteracting opioid evoked cardiorespiratory disturbances. Philos Trans R Soc Lond B Biol Sci 2009;364:2611-2623
37. Eriksson TM, Golkar A, Ekstrom JC, Svenningsson P, Ogren SO. 5-HT7 receptor stimulation by 8-OH-DPAT counteracts the impairing effect of 5-HT(1A) receptor stimulation on contextual learning in mice. Eur J Pharmacol 2008;596:107-110
38. Kellett DO, Ramage AG, Jordan D. Central 5-HT7 receptors are critical for reflex activation of cardiac vagal drive in anaesthetized rats. J Physiol 2005;563:319-331
39. Damaso EL, Bonagamba LG, Kellett DO, Jordan D, Ramage AG, Machado BH. Involvement of central 5-HT7 receptors in modulation of cardiovascular reflexes in awake rats. Brain Res 2007;1144:82-90
40. White DA, Reitan JA, Kien ND, Thorup SJ. Decrease in vascular resistance in the isolated canine hindlimb after graded doses of alfentanil, fentanyl, and sufentanil. Anesth Analg 1990;71:29-34
41. Lutsep HL. Repinotan, a 5-HT1A agonist, in the treatment of acute ischemic stroke. Curr Drug Targets CNS Neurol Disord 2005;4:119-120
42. Hutto CW Jr, Crowder WF. Dosage choices of rats for morphine, for heroin, and between morphine and heroin. Pharmacol Biochem Behav 1997;58:133-140
43. Eisenach JC, Gebhart GF. Intrathecal amitriptyline: antinociceptive interactions with intravenous morphine and intrathecal clonidine, neostigmine, and carbamylcholine in rats. Anesthesiology 1995;83:1036-1045
44. Sandkuhler J, Gebhart GF. Characterization of inhibition of a spinal nociceptive reflex by stimulation medially and laterally in the midbrain and medulla in the pentobarbital-anesthetized rat. Brain Res 1984;305:67-76
45. Bonnefont J, Chapuy E, Clottes E, Alloui A, Eschalier A. Spinal 5-HT1A receptors differentially influence nociceptive processing according to the nature of the noxious stimulus in rats: effect of WAY-100635 on the antinociceptive activities of paracetamol, venlafaxine and 5-HT. Pain 2005;114:482-490